|
Name |
pre-calidodehydroaustin
|
Molecular Formula | C32H36O11 | |
IUPAC Name* |
(8-acetyloxy-2,2',2',9,13-pentamethyl-6,16-dimethylidene-6',11,15-trioxospiro[10,14,17-trioxapentacyclo[7.6.1.17,12.01,12.02,7]heptadecane-5,3'-pyran]-3-yl)2-methylbut-2-enoate
|
|
SMILES |
C=C1C2(C=CC(=O)OC2(C)C)CC(OC(=O)C(C)=CC)C2(C)C13OC14C(=O)OC(C)(C(=C)C12C(=O)OC4C)C3OC(C)=O
|
|
InChI |
InChI=1S/C32H36O11/c1-11-15(2)22(35)40-20-14-29(13-12-21(34)41-26(29,7)8)17(4)31-23(39-19(6)33)27(9)16(3)30(28(20,31)10)24(36)38-18(5)32(30,43-31)25(37)42-27/h11-13,18,20,23H,3-4,14H2,1-2,5-10H3/b15-11+/t18-,20-,23-,27+,28-,29+,30+,31+,32-/m0/s1
|
|
InChIKey |
MZZVAYWHPCUDLE-KRQRTVANSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 596.63 | ALogp: | 3.0 |
HBD: | 0 | HBA: | 11 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 140.7 | Aromatic Rings: | 6 |
Heavy Atoms: | 43 | QED Weighted: | 0.204 |
Caco-2 Permeability: | -5.212 | MDCK Permeability: | 0.00002110 |
Pgp-inhibitor: | 0.999 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.77 | 20% Bioavailability (F20%): | 0.998 |
30% Bioavailability (F30%): | 0.975 |
Blood-Brain-Barrier Penetration (BBB): | 0.163 | Plasma Protein Binding (PPB): | 71.17% |
Volume Distribution (VD): | 2.031 | Fu: | 29.72% |
CYP1A2-inhibitor: | 0.004 | CYP1A2-substrate: | 0.948 |
CYP2C19-inhibitor: | 0.385 | CYP2C19-substrate: | 0.819 |
CYP2C9-inhibitor: | 0.416 | CYP2C9-substrate: | 0.019 |
CYP2D6-inhibitor: | 0.048 | CYP2D6-substrate: | 0.027 |
CYP3A4-inhibitor: | 0.906 | CYP3A4-substrate: | 0.931 |
Clearance (CL): | 2.456 | Half-life (T1/2): | 0.01 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.707 |
Drug-inuced Liver Injury (DILI): | 0.947 | AMES Toxicity: | 0.954 |
Rat Oral Acute Toxicity: | 0.968 | Maximum Recommended Daily Dose: | 0.378 |
Skin Sensitization: | 0.021 | Carcinogencity: | 0.968 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.569 |
Respiratory Toxicity: | 0.66 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003159 | 0.880 | D0H2MO | 0.244 | ||||
ENC005316 | 0.880 | D0E9KA | 0.241 | ||||
ENC003179 | 0.880 | D03ZZK | 0.231 | ||||
ENC005315 | 0.767 | D0G7KJ | 0.225 | ||||
ENC003309 | 0.694 | D0KR9U | 0.223 | ||||
ENC003776 | 0.679 | D08BDT | 0.203 | ||||
ENC006040 | 0.674 | D0OL7F | 0.203 | ||||
ENC004311 | 0.669 | D09WYX | 0.202 | ||||
ENC004810 | 0.667 | D02HSB | 0.199 | ||||
ENC004811 | 0.609 | D0O5WP | 0.199 |